Prostate cancer segregation analyses using 4390 families from UK and Australian population-based studies

Genetic Epidemiology

Volumn 34, Issue 1, 2010, Pages 42-50

  MacInnis, Robert J ^a,b   Antoniou, Antonis C ^a   Eeles, Rosalind A ^c,d   Severi, Gianluca ^e   Guy, Michelle ^c   McGuffog, Lesley ^a   Hall, Amanda L ^c,d   O'Brien, Lynne T ^c   Wilkinson, Rosemary A ^c   Dearnaley, David P ^c,d   Ardern Jones, Audrey T ^d   Horwich, Alan ^c,d   Khoo, Vincent S ^c,d   Parker, Christopher C ^c,d   Huddart, Robert A ^c,d   McCredie, Margaret R ^f   Smith, Charmaine ^e   Southey, Melissa C ^b   Staples, Margaret P ^g   English, Dallas R ^b,e   Hopper, John L ^b   Giles, Graham G ^b,e   Easton, Douglas F ^a   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e CANCER EPIDEMIOLOGY CENTRE   (Australia)

^f UNIVERSITY OF OTAGO   (New Zealand)

^g MONASH UNIVERSITY   (Australia)

Author keywords

Genetic; Genetic predisposition to disease; Genetics; Models; Multifactorial inheritance; Pedigree; Prostatic neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; AUTOSOMAL DOMINANT INHERITANCE; CANCER SUSCEPTIBILITY; FAMILY; FATHER; GENE FREQUENCY; GENE NUMBER; GENE SEGREGATION; GENETIC MODEL; GENETIC SUSCEPTIBILITY; GENOTYPE; GEOMETRY; HOMOZYGOTE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MULTIFACTORIAL INHERITANCE; PEDIGREE ANALYSIS; POPULATION BASED CASE CONTROL STUDY; PREDICTION; PROSTATE CANCER; RECESSIVE INHERITANCE; RISK FACTOR; SEGREGATION ANALYSIS; SIBLING; UNITED KINGDOM; X CHROMOSOME LINKAGE;

ADULT; ADULT CHILDREN; AGED; AGED, 80 AND OVER; AUSTRALIA; CASE-CONTROL STUDIES; FATHERS; GENES, RECESSIVE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; PROSTATIC NEOPLASMS; RISK FACTORS; SIBLINGS;

EID: 75649120390     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.20433     Document Type: Article

References (49)

1. Agalliu I, Karlins E, Kwon EM, Iwasaki LM, Diamond A, Ostrander EA, Stanford JL. 2007. Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer. Br J Cancer 97:826-831.
2. AIHW (Australian Institute of Health and Welfare) & AACR (Australasian Association of Cancer Registries). 2007. Cancer in Australia: an overview, 2006. Cancer series no. 37. Cat. no. CAN 32. Canberra: AIHW.
3. Akaike H. 1974. A new look at the statistical model identification. IEEE Trans Automat Control 19:716-726.
4. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Cazier JB, Sainz J, Jakobsdottir M, Kostic J, Magnusdottir DN, Ghosh S, Agnarsson K, Birgisdottir B, Le Roux L, Olafsdottir A, Blondal T, Andresdottir M, Gretarsdottir OS, Bergthorsson JT, Gudbjartsson D, Gylfason A, Thorleifsson G, Manolescu A, Kristjansson K, Geirsson G, Isaksson H, Douglas J, Johansson JE, Bälter K, Wiklund F, Montie JE, Yu X, Suarez BK, Ober C, Cooney KA, Gronberg H, Catalona WJ, Einarsson GV, Barkardottir RB, Gulcher JR, Kong A, Thorsteinsdottir U, Stefansson K. 2006. A common variant associated with prostate cancer in European and African populations. Nat Genet 38:652-658.
5. Antoniou AC, Pharoah PD, McMullan G, Day NE, Ponder BA, Easton D. 2001. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol 21:1-18.
6. Cannings C, Thompson EA. 1978. Probability functions on complex pedigrees. Adv Appl Prob 10:26-61.
7. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. 1992. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 89:3367-3371.
8. Conlon EM, Goode EL, Gibbs M, Stanford JL, Badzioch M, Janer M, Kolb S, Hood L, Ostrander EA, Jarvik GP, Wijsman EM. 2003. Oligogenic segregation analysis of hereditary prostate cancer pedigrees: evidence for multiple loci affecting age at onset. Int J Cancer 105:630-635.
9. Cui J, Staples MP, Hopper JL, English DR, McCredie MR, Giles GG. 2001. Segregation analyses of 1,476 population-based Australian families affected by prostate cancer. Am J Hum Genet 68:1207-1218.
10. Cybulski C, Górski B, Debniak T, Gliniewicz B, Mierzejewski M, Masojć B, Jakubowska A, Matyjasik J, Z"owocka E, Sikorski A, Narod SA, Lubiński J. 2004. NBS1 is a prostate cancer susceptibility gene. Cancer Res 64:1215-1219.
11. Cybulski C, Woko"orczyk D, Huzarski T, Byrski T, Gronwald J, Górski B, Debniak T, Masojć B, Jakubowska A, Gliniewicz B, Kwias Z, Antczak A, Krajka K, Lauer W, Sosnowski M, Sikorska-Radek P, Bar K, Klijer R, Zdrojowy R, Ma"kiewicz B, Borkowski A, Borkowski T, Szwiec M, Narod SA, Lubiński J. 2006. A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer. J Med Genet 43:863-866.
12. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK, Mulholland S, Leongamornlert DA, Edwards SM, Morrison J, Field HI, Southey MC, Severi G, Donovan JL, Hamdy FC, Dearnaley DP, Muir KR, Smith C, Bagnato M, Ardern-Jones AT, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Cox A, Lewis S, Brown PM, Jhavar SG, Tymrakiewicz M, Lophatananon A, Bryant SL; UK Genetic Prostate Cancer Study Collaborators; British Association of Urological Surgeons' Section of Oncology; UK ProtecT Study Collaborators , Horwich A, Huddart RA, Khoo VS, Parker CC, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Fisher C, Jamieson C, Cooper CS, English DR, Hopper JL, Neal DE, Easton DF. 2008. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 40:316-321.
13. Elston RC. 1990. Models for discrimination between alternative models of inheritance. In: Gianola D, Hammond F, editors. Advances in Statistical Methods for Genetic Improvement of Livestock. Berlin: Springer, p 41-55.
14. Etzioni R, Cha R, Feuer EJ, Davidov O. 1998. Asymptomatic incidence and duration of prostate cancer. Am J Epidemiol 148:775-785.
15. Fernando RL, Stricker C, Elston RC. 1994. The finite polygenic mixed model: an alternative formulation for the mixed model of inheritance. Theor Appl Genet 88:573-580.
16. Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, Waliszewska A, Penney K, Steen RG, Ardlie K, John EM, Oakley-Girvan I, Whittemore AS, Cooney KA, Ingles SA, Altshuler D, Henderson BE, Reich D. 2006. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci USA 103:14068-14073.
17. Gann PH, Hennekens CH, Stampfer MJ. 1995. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. J Am Med Assoc 273:289-294.
18. Giles GG, Severi G, McCredie MR, English DR, JohnsonW, Hopper JL, Boyle P. 2001. Smoking and prostate cancer: findings from an Australian case-control study. Ann Oncol 12:761-765.
19. Gong G, Oakley-Girvan I, Wu AH, Kolonel LN, John EM, West DW, Felberg A, Gallagher RP, Whittemore AS. 2002. Segregation analysis of prostate cancer in 1,719 white, African-American and Asian-American families in the United States and Canada. Cancer Causes Control 13:471-482.
20. Gronberg H, Damber L, Damber JE, Iselius L. 1997. Segregation analysis of prostate cancer in Sweden: support for dominant inheritance. Am J Epidemiol 146:552-557.
21. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, Helgason A, Rafnar T, Bergthorsson JT, Agnarsson BA, Baker A, Sigurdsson A, Benediktsdottir KR, Jakobsdottir M, Xu J, Blondal T, Kostic J, Sun J, Ghosh S, Stacey SN, Mouy M, Saemundsdottir J, Backman VM, Kristjansson K, Tres A, Partin AW, Albers-Akkers MT, Godino-Ivan Marcos J, Walsh PC, Swinkels DW, Navarrete S, Isaacs SD, Aben KK, Graif T, Cashy J, Ruiz-Echarri M, Wiley KE, Suarez BK, Witjes JA, Frigge M, Ober C, Jonsson E, Einarsson GV, Mayordomo JI, Kiemeney LA, Isaacs WB, Catalona WJ, Barkardottir RB, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K. 2007a. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 39:631-637.
22. Gudmundsson J, Sulem P, Steinthorsdottir V, Bergthorsson JT, Thorleifsson G, Manolescu A, Rafnar T, Gudbjartsson D, Agnarsson BA, Baker A, Sigurdsson A, Benediktsdottir KR, Jakobsdottir M, Blondal T, Stacey SN, Helgason A, Gunnarsdottir S, Olafsdottir A, Kristinsson KT, Birgisdottir B, Ghosh S, Thorlacius S, Magnusdottir D, Stefansdottir G, Kristjansson K, Bagger Y, Wilensky RL, Reilly MP, Morris AD, Kimber CH, Adeyemo A, Chen Y, Zhou J, So WY, Tong PC, Ng MC, Hansen T, Andersen G, Borch-Johnsen K, Jorgensen T, Tres A, Fuertes F, Ruiz-Echarri M, Asin L, Saez B, van Boven E, Klaver S, Swinkels DW, Aben KK, Graif T, Cashy J, Suarez BK, van Vierssen Trip O, Frigge ML, Ober C, Hofker MH, Wijmenga C, Christiansen C, Rader DJ, Palmer CN, Rotimi C, Chan JC, Pedersen O, Sigurdsson G, Benediktsson R, Jonsson E, Einarsson GV, Mayordomo JI, Catalona WJ, Kiemeney LA, Barkardottir RB, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K. 2007b. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 39:977-983.
23. Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, Gudbjartsson D, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Blondal T, Jakobsdottir M, Stacey SN, Kostic J, Kristinsson KT, Birgisdottir B, Ghosh S, Magnusdottir DN, Thorlacius S, Thorleifsson G, Zheng SL, Sun J, Chang BL, Elmore JB, Breyer JP, McReynolds KM, Bradley KM, Yaspan BL, Wiklund F, Stattin P, Lindström S, Adami HO, McDonnell SK, Schaid DJ, Cunningham JM, Wang L, Cerhan JR, St Sauver JL, Isaacs SD, Wiley KE, Partin AW,Walsh PC, Polo S, Ruiz-Echarri M, Navarrete S, Fuertes F, Saez B, Godino J, Weijerman PC, Swinkels DW, Aben KK, Witjes JA, Suarez BK, Helfand BT, Frigge ML, Kristjansson K, Ober C, Jonsson E, Einarsson GV, Xu J, Gronberg H, Smith JR, Thibodeau SN, Isaacs WB, Catalona WJ, Mayordomo JI, Kiemeney LA, Barkardottir RB, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K. 2008. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 40:281-283.
24. Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Waliszewska A, Neubauer J, Tandon A, Schirmer C, McDonald GJ, Greenway SC, Stram DO, Le Marchand L, Kolonel LN, Frasco M, Wong D, Pooler LC, Ardlie K, Oakley-Girvan I, Whittemore AS, Cooney KA, John EM, Ingles SA, Altshuler D, Henderson BE, Reich D. 2007. Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 39:638-644.
25. Hasstedt SJ. 1982. A mixed-model likelihood approximation on large pedigrees. Comput Biomed Res 15:295-307.
26. Hemminki K, Czene K. 2002. Age specific and attributable risks of familial prostate carcinoma from the family-cancer database. Cancer 95:1346-1353.
27. Hemminki K, Rawal R, Bermejo JL. 2005. Prostate cancer screening, changing age-specific incidence trends and implications on familial risk. Int J Cancer 113:312-315.
28. Johns LE, Houlston RS. 2003. A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 91:789-794.
29. Lalouel JM. 1980. Probability calculations in pedigrees under complex modes of inheritance. Hum Hered 30(5):320-323.
30. Lange K. 1997. An approximate model of polygenic inheritance. Genetics 147:1423-1430.
31. Lange K, Weeks D, Boehnke M. 1988. Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE. Genet Epidemiol 5:471-472.
32. Monroe KR, Yu MC, Kolonel LN, Coetzee GA, Wilkens LR, Ross RK, Henderson BE. 1995. Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med 1:827-829.
33. Narod SA, Dupont A, Cusan L, Diamond P, Gomez JL, Suburu R, Labrie F. 1995. The impact of family history on early detection of prostate cancer. Nat Med 1:99-101.
34. Office for National Statistics. 2006. Cancer statistics - registrations, England, 2004. Series MB1 no. 35. London: Office for National Statistics.
35. Ostrander EA, Stanford JL. 2000. Genetics of prostate cancer: too many loci, too few genes. Am J Hum Genet 67:1367-1375.
36. Pakkanen S, Baffoe-Bonnie AB, Matikainen MP, Koivisto PA, Tammela TL, Deshmukh S, Ou L, Bailey-Wilson JE, Schleutker J. 2007. Segregation analysis of 1,546 prostate cancer families in Finland shows recessive inheritance. Hum Genet 121:257-267.
37. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, editors. 2003. Cancer Incidence in Five Continents. IARC Scientific Publications No.155. Lyons: International Agency for Research on Cancer.
38. Pearson JD, Luderer AA, Metter EJ, Partin AW, Chan DW, Fozard JL, Carter HB. 1996. Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer. Urology 48:4-9.
39. Schaid DJ. 2004. The complex genetic epidemiology of prostate cancer. Hum Mol Genet 13:R103-R121.
40. Schaid DJ, McDonnell SK, Blute ML, Thibodeau SN. 1998. Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet 62:1425-1438.
41. Schaid DJ, McDonnell SK, Zarfas KE, Cunningham JM, Hebbring S, Schaid DJ, McDonnell SK, Zarfas KE, Cunningham JM, Hebbring S, Thibodeau SN, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Badzioch M, Bishop DT, Evans C, Edwards S, Meitz J, Bullock S, Hope Q, Guy M, Hsieh CL, Halpern J, Balise RR, Oakley-Girvan I, Whittemore AS, Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Friedrichsen DM, Deutsch K, Kolb S, Janer M, Hood L, Ostrander EA, Stanford JL, Ewing CM, Gielzak M, Isaacs SD, Walsh PC, Wiley KE, Isaacs WB, Lange EM, Ho LA, Beebe-Dimmer JL, Wood DP, Cooney KA, Seminara D, Ikonen T, Baffoe-Bonnie A, Fredriksson H, Matikainen MP, Tammela TL, Bailey-Wilson J, Schleutker J, Maier C, Herkommer K, Hoegel JJ, Vogel W, Paiss T, Wiklund F, Emanuelsson M, Stenman E, Jonsson BA, Grönberg H, Camp NJ, Farnham J, Cannon-Albright LA, Catalona WJ, Suarez BK, Roehl KA.2006. Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Hum Genet 120:471-485.
42. The Breast Cancer Linkage Consortium. 1999. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91:1310-1316.
43. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, Yu K, Chatterjee N, Welch R, Hutchinson A, Crenshaw A, Cancel-Tassin G, Staats BJ, Wang Z, Gonzalez-Bosquet J, Fang J, Deng X, Berndt SI, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cussenot O, Valeri A, Andriole GL, Crawford ED, Tucker M, Gerhard DS, Fraumeni Jr JF, Hoover R, Hayes RB, Hunter DJ, Chanock SJ. 2008. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 40:310-315.
44. Valeri A, Briollais L, Azzouzi R, Fournier G, Mangin P, Berthon P, Cussenot O, Demenais F. 2003. Segregation analysis of prostate cancer in France: evidence for autosomal dominant inheritance and residual brother-brother dependence. Ann Hum Genet 67:125-137.
45. Verhage BA, Baffoe-Bonnie AB, Baglietto L, Smith DS, Bailey-Wilson JE, Beaty TH, Catalona WJ, Kiemeney LA. 2001. Autosomal dominant inheritance of prostate cancer: a confirmatory study. Urology 57:97-101.
46. Witte JS. 2007. Multiple prostate cancer risk variants on 8q24. Nat Genet 39:579-580.
47. Woolf CM. 1960. An investigation of the familial aspects of carcinoma of the prostate. Cancer 13:739-744.
48. Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL,Mahle L, Moller P, Bishop T, Evans C, Edwards S, Meitz J, Bullock S, Hope Q, Hsieh CL, Halpern J, Balise RN, Oakley-Girvan I, Whittemore AS, Ewing CM, Gielzak M, Isaacs SD, Walsh PC, Wiley KE, Isaacs WB, Thibodeau SN, McDonnell SK, Cunningham JM, Zarfas KE, Hebbring S, Schaid DJ, Friedrichsen DM, Deutsch K, Kolb S, Badzioch M, Jarvik GP, Janer M, Hood L, Ostrander EA, Stanford JL, Lange EM, Beebe-Dimmer JL, Mohai CE, Cooney KA, Ikonen T, Baffoe-Bonnie A, Fredriksson H, Matikainen MP, Tammela TLj, Bailey-Wilson J, Schleutker J, Maier C, Herkommer K, Hoegel JJ, Vogel W, Paiss T, Wiklund F, Emanuelsson M, Stenman E, Jonsson BA, Gronberg H, Camp NJ, Farnham J, Cannon-Albright LA, Seminara D; 2005. A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet 77:219-229.
49. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, Minichiello MJ, Fearnhead P, Yu K, Chatterjee N, Wang Z, Welch R, Staats BJ, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Gelmann EP, Tucker M, Gerhard DS, Fraumeni Jr JF, Hoover R, Hunter DJ, Chanock SJ, Thomas G. 2007. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 39:645-649.